Funding for this research was provided by:
Ministry of Science, Innovation and Higher Education | Styrelsen for Forskning og Innovation (4135-00023)
the Danish Research Foundation
Received: 19 December 2018
Accepted: 8 October 2019
First Online: 5 November 2019
: D.G.K.R., S.H.N., S.B., M.A.K. and F.G. are full-time employees at Nordic Bioscience. Nordic Bioscience is a privately-owned, small–medium size enterprise partly focused on the development of biomarkers. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. M.A.K. and F.G. hold stocks in Nordic Bioscience. The patent for the ELISAs used in the study are owned by Nordic Bioscience. The funder provided support in the form of salaries for authors D.G.K.R., S.H.N., S.B., M.A.K., and F.G., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors report no competing financial interests relevant to this manuscript.